Congenital erythrocytosis

International Journal of Laboratory Hematology

Volumn 38, Issue , 2016, Pages 59-65

  McMullin, M F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Congenital erythrocytosis; erythropoietin; erythropoietin receptor; high affinity haemoglobin; oxygen sensing pathway

Indexed keywords

ACETYLSALICYLIC ACID; ADAPTOR PROTEIN; BISPHOSPHOGLYCERATE MUTASE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR; LYMPHOCYTE ADAPTOR PROTEIN; OXYGEN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

CONGENITAL ERYTHROCYTOSIS; DEOXYGENATION; ELECTROPHORESIS; ERYTHROCYTOSIS; GENE MUTATION; GENE SEQUENCE; GENETIC VARIATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENTAL FINDING; LABORATORY TEST; LOW DRUG DOSE; METHEMOGLOBINEMIA; OXYGEN AFFINITY; OXYGEN DISSOCIATION CURVE; OXYGEN SENSING; OXYGENATION; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; UBIQUITINATION;

EID: 84978370196     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12506     Document Type: Review

References (31)

1. Johansson PL, Soodabeh S-K, Kutti J. An elevated venous hemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia. Br J Haematol 2005;129:701–5.
2. de La Chapelle A, Traskelin A-L, Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci U S A 1993;90:4495–9.
3. Percy MJ. Genetically heterogeneous origins of idiopathic erythrocytosis. Hematology 2007;12:131–9.
4. Tong W, Zhang J, Lodish HF. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signalling pathways. Blood 2005;105:4604–11.
5. McMullin MF, Cario H. LNK mutations and myeloproliferative disorders. Am J Hematol 2016;91:248–51.
6. OH ST, Zahn JM, Jones CD, et al. Identification of novel LNK mutations in patients with chronic myeloproliferative neoplasm and related disorders. Blood 2010;116:21: 315.
7. Lasho T, Pardanani A, Tefferi A. LNK mutations in JAK2 mutation-negative erythrocytosis. N Engl J Med 2010;363:1189–899.
8. Schofield C, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev 2004;5:343–54.
9. Percy MJ, Zhao Q, Flores A, Harrison C, Lappin TRJ, Maxwell PH, McMullin MF, Lee FS. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci U S A 2006;103:654–9.
10. Arsenault PR, Pei F, Lee R, Kerestes H, Percy MJ, Keith B, Simon MC, Lappin TR, Khurana TS, Lee FS. A Knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism. J Biol Chem 2013;288:33571–84.
11. Bento C, Percy MJ, Gardie B, Maia TM, van Wijk R, Perrotta S, Ragione FD, Almeida H, Rossi C, Girodon F, Aström M, Neuman D, Schnittger S, Landin B, Minkov M, Randi ML, Casadevall N, Vainchenker W, Rives S, Hermouet S, Ribeiro L, McMullin MF, Cario H, on behalf of ECE-Consortium. Genetic basis of congenital erythrocytosis: mutation update and online databases. Hum Mutat 2014;35:15–26.
12. Ladroue C, Carcenac R, Leporrier M, Gad S, Le Hello C, Galateau-Salle F, Feunteun J, Pouysségur J, Richard S, Gardie B. PHD2 mutation and congenital erythrocytosis and paragangloima. N Engl J Med 2008;359:2685–92.
13. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Liu E, Sergueeva AI, Miasnikova GY, Mole D, Maxwell PH, Stockton DW, Semenza GL, Prchal JT. Disruption of oxygen homeostasis underlies congenital Chuvash polycythaemia. Nat Genet 2002;32:614–21.
14. Percy MJ, McMullin MF, Jowitt SN, Potter M, Treacy M, Watson WH, Lappin TRJ. Chuvash congenital polycythaemia in 4 families of Asian and Western European ancestry. Blood 2003;102:1097–9.
15. Perrotta S, Novili B, Ferraro M, Migliaccio C, Borriello A, Cucciolla V, Martinelli V, Rossi F, Punzo F, Cirillo P, Parisi G, Zappia V, Rotoli B, Della Ragione F. Von Hippel-Lindau-dependent polycythaemia is endemic on the island of Ischia: identification of a novel cluster. Blood 2006;107:514–9.
16. Lui EL, Percy MJ, Amos CA, Guan Y, Shete S, Stocton DW, McMullin MF, Polyakova LA, Ang SO, Pastore YD, Jedickova K, Lappin TRJ, Gordeuk V, Guan Y, Prchal J. The worldwide distribution of the VHL598C to T Mutation indicates a single founding event. Blood 2004;103:1937–40.
17. McMullin MF. HIF pathway mutations and erythrocytosis. Exper Rev Hematol 2010;3:93–10118.
18. Percy MJ, Furlow PW, Lucas GS, Li X, Lappin TR, McMullin MF, Lee FS. A Gain-of-Function mutation in the HIF2A gene familial erythrocytosis. N Engl J Med 2008;335:52–8.
19. Perrotta S, Della Ragione F. The HIF2A gene in familial erythrocytosis. N Engl Med 2008;338:1966.
20. Percy MJ, Beer PA, Campbell G, Dekker AW, Green AR, Oscier D, Rainey G, van Wijk R, Wood M, Lappin TR, McMullin MF, Lee FS. Novel exon 12 mutations in the HIF2a gene associated with erythrocytosis. Blood 2008;111:5400–2.
21. Gale DP, Harten SK, Reid CD, Tuddenham GD, Maxwell PH. Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with HIF2□ mutation. Blood 2008;112:919–2122.
22. Rosa R, Prehu MO, Beuzard Y, Rosa J. The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes. J. Clin. Invest. 1978;62:907–15.
23. Petrousi N, Copley RR, Lappin TR, Haggan SE, Bento CM, Cario H, Percy MJ, Consortium TW, Ratcliffe PJ, Robbins PA, McMullin MF. Erythrocytosis associated with a novel missense mutation in the BPGM gene. Haematologica 2014;99:e201–4.
24. Percy MJ, Butt NN, Crotty GM, Drummond MW, Harrison C, Jones GL, Turner M, Wallis J, McMullin MF. Identification of high affinity haemoglobin variants in the investigation of patients with erythrocytosis. Haematologica 2009;94:1321–2.
25. Percy MJ, McFerran NV, Lappin TR. Disorders of oxidised haemoglobin. Blood Rev 2005;19:61–8.
26. 5 reductase deficiency. Br J Haematol 2008;141:298–308.
27. Beutler E, Westwood B, van Zwieten R, Roos D. G-T transition at cDNA nt110 (K37Q) in the PKLR (pyruvate kinase) gene is the molecular basis of a case of hereditary increase of red blood cell ATP. Human Mutat 1997;3:282–5.
28. Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin D, Voloshin Y, Choyke PL, Butman JA, Jedlickova K, Prchal JT, Polykova LA. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythaemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 2004;103:3924–9.
29. Smith TG, Brooks JT, Balanos GM, Lappin TR, Layton DM, Leedham DL, Iu C, Maxwell PH, McMullin MF, McNamara CJ, Percy MJ, Pugh CW, Ratcliffe PJ, Talbot NP, Treacy M, Robbins PA. Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiology. Adv Exp Med Biol 2008;605:51–6.
30. Russell RC, Sufan RI, Zhou B, Heir P, Bunda S, Sybingco SS, Greer SN, Roche O, Heathcote SA, Chow VW, Boba LM, Richmond TD, Hickey MM, Barber DL, Cheresh DA, Simon MC, Irwin MS, Kim WY, Oh M. Loss of JAK2 regulation via VHL-SOCS1 E3 ubiquitin heterocomplex underlies Chuvash polycythaemia. Nat Med 2011;17:845–53.
31. Ban-Hoefen M, Engle EK, Knoche EM, Kalwar C, Gordon K, Moore DM, Oh ST. The JAK inhibitor ruxolininib elicits hematologic and symptomatic improvement in patients with Chuvash polycythemia. Blood 2013;122(21):4051.